News | Radiation Therapy | September 07, 2016

ASTRO Announces Featured Clinical Trials and Research for 2016 Annual Meeting

Press program will highlight innovations in cancer care from 15 leading studies in five news briefings held live on-site and via webcast

ASTRO 2016 annual meeting, clinical trials and research, press program, radiation therapy

September 7, 2016 — The American Society for Radiation Oncology (ASTRO) announced the press program for its 58th Annual Meeting, Sept. 25-28 in Boston. The program includes multiple reports from phase III clinical trials, researchers from leading institutions in the United States and abroad, and examinations of a range of cancer types and patient populations. Researchers will share their findings in a series of briefings held on-site at the Boston Convention & Exhibition Center and webcast to registered press.

The news briefing schedule is as follows:

Meeting Overview & Report on ASTRO Initiatives

  • Sunday, Sept. 25, 2:45 - 3:15 p.m. ET
  • Features David C. Beyer, M.D., FASTRO, current president and incoming chair of ASTRO

Refining Treatment Decisions

  • Monday, Sept. 26, 8:00 - 9:00 a.m. ET
  • Features studies evaluating conventional versus accelerated treatment approaches for brain metastases, lung cancer and prostate cancer

Expanding Access to Care

  • Monday, Sept. 26, 10:30 - 11:30 a.m. ET
  • Features studies on expanding care to overlooked or growing patient populations, including elderly patients, African Americans, developing countries and veterans

Advances in Prostate Cancer Care

  • Tuesday, Sept. 27, 8:00 - 9:00 a.m. ET
  • Features large trials and multi-institution studies examining treatment advances in brachytherapy, teletherapy and biomarker subtyping for prostate cancer

Innovations in RT Delivery

  • Tuesday, Sept. 27, 1:30 p.m. - 2:30 p.m. ET
  • Features reports of how new approaches to radiation therapy delivery impact disease control and quality of life for gynecologic, breast and pediatric brain cancers

 

The 2016 ASTRO Annual Meeting is expected to attract more than 11,000 attendees from across the globe, including oncologists from all disciplines and members of the entire radiation oncology team. The meeting will feature abstracts, scientific and educational presentations on radiation oncology clinical trials and research, and keynote addresses from former U.S. Secretary of Health and Human Services Kathleen Sebelius, the current chair and CEO of the Massachusetts General Physicians Organization and a top safety executive from Delta Air Lines.

Led by Beyer, the 2016 meeting is organized around the theme, “Enhancing Value, Improving Outcomes,” echoing growing calls from policy makers, physicians and patients for value-based health care. Concurrent with the scientific and educational program, more than 200 exhibitors will demonstrate the latest cutting-edge technology and medical device innovations for radiation oncology.

For more information: www.astro.org

Related Content

Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Machine Learning Uncovers New Insights Into Human Brain Through fMRI
News | Neuro Imaging | January 11, 2019
An interdisciplinary research team led by scientists from the National University of Singapore (NUS) has successfully...
Mobile App Data Collection Shows Promise for Population Health Surveys
News | Population Health | January 10, 2019
Mobile app data collection can bring access to more potential clinical study participants, reduce clinical study...
Hypertension With Progressive Cerebral Small Vessel Disease Increases Cognitive Impairment Risk
News | Magnetic Resonance Imaging (MRI) | January 08, 2019
Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of...
Artificial Intelligence Pinpoints Nine Different Abnormalities in Head Scans

A brain scan (left) showing an intraparenchymal hemorrhage in left frontal region and a scan (right) of a subarachnoid hemorrhage in the left parietal region. Both conditions were accurately detected by the Qure.ai tool. Image courtesy of Nature Medicine.

News | Artificial Intelligence | January 07, 2019
The rise in the use of computed tomography (CT) scans in U.S. emergency rooms has been a well-documented trend1 in...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
Breast Cancer Patients Have Less Heart Damage With Heart Drug and Trastuzumab
News | Cardio-oncology | January 03, 2019
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a...